These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1987 related items for PubMed ID: 18840379
21. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1. Lee BH, Park JS, Park JH, Park JS, Kwak JJ, Hwang ES, Kim SK, Choi DH, Kim YH, Pak HN. J Cardiovasc Electrophysiol; 2010 May; 21(5):501-7. PubMed ID: 20021521 [Abstract] [Full Text] [Related]
22. Stroke prevention in atrial fibrillation: are we following the guidelines? Pusser BE, Robertson SL, Robinson MD, Barton C, Dobson LA. N C Med J; 2005 May; 66(1):9-13. PubMed ID: 15786672 [Abstract] [Full Text] [Related]
23. [Oral anticoagulant use in patients with atrial fibrillation]. Ertaş F, Duygu H, Acet H, Eren NK, Nazli C, Ergene AO. Turk Kardiyol Dern Ars; 2009 Apr; 37(3):161-7. PubMed ID: 19553738 [Abstract] [Full Text] [Related]
24. Quality of care for atrial fibrillation among patients hospitalized for heart failure. Piccini JP, Hernandez AF, Zhao X, Patel MR, Lewis WR, Peterson ED, Fonarow GC, Get With The Guidelines Steering Committee and Hospitals. J Am Coll Cardiol; 2009 Sep 29; 54(14):1280-9. PubMed ID: 19778670 [Abstract] [Full Text] [Related]
25. Short-term prevention of thromboembolic complications in patients with atrial fibrillation with aspirin plus clopidogrel: the Clopidogrel-Aspirin Atrial Fibrillation (CLAAF) pilot study. Lorenzoni R, Lazzerini G, Cocci F, De Caterina R. Am Heart J; 2004 Jul 29; 148(1):e6. PubMed ID: 15215815 [Abstract] [Full Text] [Related]
26. Anticoagulation for patients with atrial fibrillation in ambulatory care settings. Niska R, Han B. J Am Board Fam Med; 2009 Jul 29; 22(3):299-306. PubMed ID: 19429736 [Abstract] [Full Text] [Related]
27. Predictors of warfarin use among Ohio medicaid patients with new-onset nonvalvular atrial fibrillation. Johnston JA, Cluxton RJ, Heaton PC, Guo JJ, Moomaw CJ, Eckman MH. Arch Intern Med; 2003 Jul 28; 163(14):1705-10. PubMed ID: 12885686 [Abstract] [Full Text] [Related]
28. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1. Gorin L, Fauchier L, Nonin E, de Labriolle A, Haguenoer K, Cosnay P, Babuty D, Charbonnier B. Thromb Haemost; 2010 Apr 28; 103(4):833-40. PubMed ID: 20135077 [Abstract] [Full Text] [Related]
29. [New international guidelines on antithrombotic therapy in atrial fibrillation]. Tveit A. Tidsskr Nor Laegeforen; 2009 Jun 25; 129(13):1332-5. PubMed ID: 19561659 [Abstract] [Full Text] [Related]
30. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. Arch Intern Med; 1996 Feb 26; 156(4):409-16. PubMed ID: 8607726 [Abstract] [Full Text] [Related]
31. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter. Cairns JA, Connolly S, McMurtry S, Stephenson M, Talajic M, CCS Atrial Fibrillation Guidelines Committee. Can J Cardiol; 2011 Feb 26; 27(1):74-90. PubMed ID: 21329865 [Abstract] [Full Text] [Related]
32. Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. Waldo AL, Becker RC, Tapson VF, Colgan KJ, NABOR Steering Committee. J Am Coll Cardiol; 2005 Nov 01; 46(9):1729-36. PubMed ID: 16256877 [Abstract] [Full Text] [Related]
33. Current practice of antithrombotic treatment in ischemic stroke: a survey among Hungarian neurologists. Sztriha LK, Vécsei L. Ideggyogy Sz; 2008 May 30; 61(5-6):148-54. PubMed ID: 18567389 [Abstract] [Full Text] [Related]
34. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials. Flaker GC, Gruber M, Connolly SJ, Goldman S, Chaparro S, Vahanian A, Halinen MO, Horrow J, Halperin JL, SPORTIF Investigators. Am Heart J; 2006 Nov 30; 152(5):967-73. PubMed ID: 17070169 [Abstract] [Full Text] [Related]
35. Antithrombotic therapy practices in US hospitals in an era of practice guidelines. Tapson VF, Hyers TM, Waldo AL, Ballard DJ, Becker RC, Caprini JA, Khetan R, Wittkowsky AK, Colgan KJ, Shillington AC, NABOR (National Anticoagulation Benchmark and Outcomes Report) Steering Committee. Arch Intern Med; 2005 Jul 11; 165(13):1458-64. PubMed ID: 16009860 [Abstract] [Full Text] [Related]
36. Preference-based antithrombotic therapy in atrial fibrillation: implications for clinical decision making. Man-Son-Hing M, Gage BF, Montgomery AA, Howitt A, Thomson R, Devereaux PJ, Protheroe J, Fahey T, Armstrong D, Laupacis A. Med Decis Making; 2005 Jul 11; 25(5):548-59. PubMed ID: 16160210 [Abstract] [Full Text] [Related]
37. Anticoagulation in atrial fibrillation. Anderson M, Kirk M. Med Health R I; 2004 Apr 11; 87(4):98-100. PubMed ID: 15168633 [Abstract] [Full Text] [Related]
39. Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls. Garwood CL, Corbett TL. Ann Pharmacother; 2008 Apr 11; 42(4):523-32. PubMed ID: 18334606 [Abstract] [Full Text] [Related]
40. Safety and effectiveness of antithrombotic strategies in older adult patients with atrial fibrillation and non-ST elevation myocardial infarction. Fosbol EL, Wang TY, Li S, Piccini JP, Lopes RD, Shah B, Mills RM, Klaskala W, Alexander KP, Thomas L, Roe MT, Peterson ED. Am Heart J; 2012 Apr 11; 163(4):720-8. PubMed ID: 22520540 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]